CAR-T cell therapy: a potential new strategy against prostate cancer-Reference-Cited by-同舟云学术

CAR-T cell therapy: a potential new strategy against prostate cancer

Published:2019-10-16 Issue:1 Volume:7 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Schepisi Giuseppe,Cursano Maria Concetta,Casadei Chiara,Menna Cecilia,Altavilla Amelia,Lolli Cristian,Cerchione Claudio,Paganelli Giovanni,Santini Daniele,Tonini Giuseppe,Martinelli Giovanni,De Giorgi Ugo

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-019-0741-7.pdf

Reference122 articles.

1. Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67:177–93. https://doi.org/10.3322/caac.21395 .

2. Drake CG. Prostate cancer as a model for tumour immunotherapy. Nat Rev Immunol. 2010;10:580–93. https://doi.org/10.1038/nri2817 .

3. Schepisi G, Farolfi A, Conteduca V, Martignano F, De Lisi D, Ravaglia G, et al. Immunotherapy for prostate cancer: Where we are headed. Int J Mol Sci. 2017;18:e2627. https://doi.org/10.3390/ijms18122627 .

4. Topalian S, Hodi F. Safety, activity, and immune correlates of anti–PD-1 antibody in cancer. N Engl J Med. 2012;366:2443–54. https://doi.org/10.1056/NEJMoa1200690 .

5. Kwon ED, Drake CG, Scher HI, Fizazi K, Bossi A, van den Eertwegh AJM, et al. Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184–043): a multicentre, randomised, double-blind, phase 3 trial. Lancet Oncol. 2014;15:700–12. https://doi.org/10.1016/S1470-2045(14)70189-5 .

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanomedicines in diagnosis and treatment of prostate cancers: an updated review;Frontiers in Bioengineering and Biotechnology;2024-08-21

2. Can Prostate Cancer Patients be Prescribed Chinese Herbal Medicine? A Review of its Potential Modulatory Effects on the Androgen Receptor;Integrative Medicine in Nephrology and Andrology;2024-07-31

3. The reactive stroma response regulates the immune landscape in prostate cancer;Journal of Translational Genetics and Genomics;2024-07-24

4. CAR-T cell-derived exosomes: a new perspective for cancer therapy;Stem Cell Research & Therapy;2024-06-18

5. Dual immunotherapy alternating with anti-PD-1 antibody plus liposomal doxorubicin show good efficacy in prostate epithelioid hemangioendothelioma: a case report;Frontiers in Immunology;2024-06-14